FDA Approves Weekly Contraceptive Patch Twirla FDA Approves Weekly Contraceptive Patch Twirla

Twirla is a levonorgestrel and ethinyl estradiol transdermal contraceptive option for women with a BMI

Source: Medscape Medical News Headlines - February 18, 2020 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Alert Source Type: news